Moxetumomab pasudotox and Tapentadol Extended-Release Tablets
Determining the interaction of Moxetumomab pasudotox and Tapentadol Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: tapentadol
Brand name: Nucynta, Nucynta ER
Synonyms: Tapentadol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Tapentadol Hydrochloride
- Moxetumomab pasudotox-Tapentadol Tablets
- Moxetumomab pasudotox-TaperDex 12-day
- Moxetumomab pasudotox-TaperDex 6-day
- Moxetumomab pasudotox-TaperDex 7-day
- Moxetumomab pasudotox-Tar Distillate Topical
- Tapentadol Extended-Release Tablets-Moxetumomab Pasudotox-tdfk
- Tapentadol Extended-Release Tablets-Moxetumomab pasudotox-tdfk Intravenous
- Tapentadol Extended-Release Tablets-Moxifloxacin
- Tapentadol Extended-Release Tablets-Moxifloxacin (Systemic)
- Tapentadol Extended-Release Tablets-Moxifloxacin Hydrochloride
- Tapentadol Extended-Release Tablets-Moxifloxacin Injection